.

Brain Tumor Meeting 2019: May 23 / 24, 2019 - Save the date!

Welcome Address 2017

We are pleased to announce that the Brain Tumor Meeting 2017 will take place at the Max Delbrück Center für Molecular Medicine (MDC) in Berlin (Germany) on May 18 - 19, 2017.
In summer 2000 Berlin neuroscientists, neurosurgeons and neurologists focusing on brain tumors initiated this scientific conference series. It was repeated in 2001, 2004, 2006, 2008, 2011, 2013, and 2015 - throughout this time the Brain Tumor Meeting gained national and international attention and attracted many leading scientist working on brain tumors.
The main focus of the meeting is to provide a platform for an interdisciplinary scientific exchange especially between scientists and clinicians. Recent discoveries on the role of glioma stem cells, on the interaction of gliomas with their microenvironment and on glioma cell death pathways have altered our understanding of glioma biology.
Internationally renowned speaker agreed to present their newest data on these topics. Furthermore, abstracts for oral and poster presentations are invited and the best presentations will be awarded a price.
We expect exciting scientific exchange and invite you to join this meeting.

The Scientific Committee

       

 

 

Scientific Committee:
Christoph Harms, Charité Campus Mitte, Berlin
Frank Heppner, Charité Campus Mitte, Berlin
Helmut Kettenmann (Chair), MDC, Berlin-Buch
Jürgen Kiwit, Helios Klinikum, Berlin-Buch
Michael Synowitz (Co-Chair), UKSH, Kiel
Peter Vajkoczy, Charité Virchow-Klinikum, Berlin
Susanne Wolf, MDC, Berlin-Buch
 
Conference Management:
Meino Alexandra Gibson
Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch
Robert-Rössle-Str. 10
13125 Berlin, Germany
Phone: +49 30 9406 3336
 
This meeting is an activity of
Max Delbrück Center for Molecular Medicine
Helios Klinikum Berlin-Buch
Charité - Campus Mitte
Charité - Campus Virchow - Klinikum
Universitätsklinikum Kiel
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

       

 
Best Abstract Competition
Three Prizes are awarded for the best three abstracts presented at the Brain Tumor 2015 meeting. A two-tier assessment is used to determine the Best Poster Prize. i.e. (1) scoring by the program committee members and (2) voting by the meeting participants.
 
1. Prize: IPad pro
Buonfiglioli, Alice
Cellular Neurosciences, Max-Delbrück-Centrum für Molekulare Medizin, Robert-Rössle-Str. 10, 13092 Berlin, alice.buonfiglioli@mdc-berlin.de
THE ROLE OF LET-7 MICRORNAS AS ACTIVATORS OF GLIOMA-ASSOCIATED MICROGLIA/MACROPHAGES
Buonfiglioli, A.; Wolf, S.; Kettenmann, H.; Lehnardt, S.
 
2. Prize: IPad mini
Di Tacchio, Mariangela
Institute of Neurology Edinger Institute, Medical School Goethe University Frankfurt, Heinrich-Hoffmann-Str. 7, 60528 Frankfurt am Main, Mariangela.DiTacchio@kgu.de
ENDOTHELIAL CELL-DERIVED ANGIOPOIETIN-2 IS A THERAPEUTIC TARGET IN TREATMENT-NAIVE AND  BEVACIZUMAB-RESISTANT GLIOBLASTOMA
Di Tacchio, M.; Scholz, A.; Harter, P. N.; Cremer, S.; Yalcin, B. H.; Gurnik, S.; Plate K. H.; Reiss
 
3. Prize: Apple watch
Willems, Estelle
GIGA-Neuroscience, University of Liége, Avenue Hippocrate, 15, 4000 Liége, Belgium, estelle.willems@doct.ulg.ac.be
ROLE OF AURORA KINASE A IN THE THERAPEUTIC RESISTANCE OF GLIOBLASTOMA ASSOCIATED WITH THE PRODUCTION OF CXCL12 IN THE SUBVENTRIC
Willems, E; Dedobbeleer, M; Digregorio, M; Lombard, A1,; Lumapat, P; Lambert, J; Szpakowska, M; Chevigné, A; Scholtes, F; Rogister, B.
 
Congratulations!
 
 
 
 
 
 

 

 

 

 
 

Sponsors

 

         Cyagen Animal Model Award

    

Commercial partners are invited to place their logos here. For more sponsoring opportunities please contact the organizers.